Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor

Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor

ObjectiveTo compare the efficacy and safety of different-course corticosteroids plus mycophenolate mofetil (MMF) as maintenance therapy in autoimmune encephalitis (AE) with neuronal surface antibodies (NSAbs) without tumor and explore the optimal course of corticosteroids.MethodsFifty-five patients...

Full description

Bibliographic Details
Main Authors:	Dong Li, Teng Huang, Fangyuan Zhang, Xiaoyu Zhang, Jingjing Dou, Chunjuan Wang, Shougang Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Immunology
Subjects:	autoimmune encephalitis neuronal surface antibodies corticosteroids mycophenolate mofetil courses efficacy and safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1195172/full

Similar Items

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)

Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
by: Qing Jia, et al.
Published: (2022-08-01)

Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
by: David Dias-Polak, et al.
Published: (2019-01-01)

Effectiveness of Mycophenolate Mofetil in the Treatment of Pediatric Anti-NMDAR Encephalitis: A Retrospective Analysis of 6 Cases
by: Xiao-sheng Hao, et al.
Published: (2020-11-01)

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
by: R. S. Rud, et al.
Published: (2021-12-01)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
by: Agnieszka Ewa Sieradzka, et al.
Published: (2022-07-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01)

Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases
by: Xiao-sheng Hao, et al.
Published: (2023-03-01)

Outcomes of Late Corticosteroid Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials
by: AK Ali, et al.
Published: (2011-10-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
by: Olga Blagova, et al.
Published: (2023-07-01)

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01)

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

Mycophenolate mofetil in giant cell arteritis
by: Anne Pankow, et al.
Published: (2023-11-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Pharmacokinetics of mycophenolic acid and its effect on CD4+ and CD8+ T cells after oral administration of mycophenolate mofetil to healthy cats
by: Jennifer E. Slovak, et al.
Published: (2019-09-01)

Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
by: Mehmet Usta, et al.
Published: (2019-10-01)

Simultaneous Spectrophotometric Determination of Mycophenolate Mofetil and Its Active Metabolite in Human Plasma Using Chemometrics Methods
by: Tayyebeh Madrakian, et al.
Published: (2015-06-01)

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
by: Fatemeh Hayati, et al.
Published: (2019-04-01)

Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves’ orbitopathy: a meta-analysis
by: Wenwen Feng, et al.
Published: (2022-06-01)

Protective effect of melatonin and mycophenolate mofetil against nephrotoxicity induced by tacrolimus in wistar rats
by: Suleyman KOC, et al.
Published: (2021-11-01)

Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using <i>Ex Vivo</i> T Cell Function Assays
by: Aliede E. in ’t Veld, et al.
Published: (2023-05-01)

Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats
by: Rodrigo Oscar Marañón, et al.
Published: (2023-11-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
by: Ryousuke Satou, et al.
Published: (2022-07-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
by: Mirjam Kolev, et al.
Published: (2022-01-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
by: Tomoko Mizaki, et al.
Published: (2023-01-01)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
by: Lan-Fang Li, et al.
Published: (2023-03-01)

Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
by: Rubén Berrueco, et al.
Published: (2023-10-01)

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
by: Maria De Santis, et al.
Published: (2022-05-01)

Post COVID‐19 organizing pneumonia treated with mycophenolate mofetil
by: Hui Xin Tan, et al.
Published: (2022-11-01)

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil
by: Mumina Akthar, et al.
Published: (2023-06-01)